Broccoli Sprout Extract in Treating Patients With Breast Cancer
A Pilot Study of Broccoli Sprout Extract in Patients With Breast Cancer
Sponsor: National Cancer Institute (NCI)
This EARLY_PHASE1 trial investigates Ductal Breast Carcinoma and Ductal Breast Carcinoma In Situ and is currently completed. National Cancer Institute (NCI) leads this study, which shows 11 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Nov 2019 — Jan 2021 [monthly]
Completed EARLY_PHASE1
Phase: NA → EARLY_PHASE1
-
Sep 2019 — Nov 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Dec 2018 — Sep 2019 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Roswell Park Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .